157037-56-4

Basic information

• Product Name: alpha-D-erythro-Pentofuranous-2-ulose 1,3,5-tribenzoate
• Synonyms: alpha-D-erythro-Pentofuranous-2-ulose 1,3,5-tribenzoate;1,3,5-tribenzoate-alpha-D-erythro-Pentofuranos-2-ulose;1,3,5-tri-O-benzoyl-2-oxo-alpha-D-erythro-pentofuranose;a-D-erythro-Pentofuranos-2-ulose, 1,3,5-tribenzoate;1,3,5-tri-O-benzoyl-2-oxo-α-D-erythro-pentofuranose;1,3,5-tri-o-benzoyl-2-oxo-a-d-erythro-pentofuranose
• CAS NO: 157037-56-4
• Molecular Formula: C₂₆H₂₀O₈
• Molecular Weight: 460.43
• Mol File: 157037-56-4.mol
• Article Data: 21

Chemical Properties

• Appearance: /
• Density: 1.37
• CAS DataBase Reference: alpha-D-erythro-Pentofuranous-2-ulose 1,3,5-tribenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: alpha-D-erythro-Pentofuranous-2-ulose 1,3,5-tribenzoate(157037-56-4)
• EPA Substance Registry System: alpha-D-erythro-Pentofuranous-2-ulose 1,3,5-tribenzoate(157037-56-4)

Safety Data

• Hazardous Substances Data: 157037-56-4(Hazardous Substances Data)

Usage

General Description

Alpha-D-erythro-Pentofuranous-2-ulose 1,3,5-tribenzoate is a synthetic chemical compound with a complex molecular structure. It is derived from D-ribose, a naturally occurring sugar. The compound is used in the field of organic chemistry as a building block for the synthesis of other molecules. Its tribenzoate group makes it a versatile reagent for various reactions, and it can be utilized in the production of pharmaceuticals, agrochemicals, and other fine chemicals. Additionally, the compound may have potential applications in the development of new materials and advanced technologies. Its unique properties and versatile nature make it a valuable tool for researchers and chemists in the pursuit of new chemical compounds and applications.

Upstream product

• 69339-86-2 1,2,3,5-tetra-O-benzoyl-α-D-ribofuranoside 
• 22224-41-5 1,3,5-tri-O-benzoyl-α-D-ribofuranoside 

Downstream Products

• 1443997-84-9 C₃₆H₃₀O₉ 
• 1443997-83-8 C₃₆H₂₈O₉ 
• 1443997-54-3 (2R,3R,4R,5R)-5-((benzoyloxy)methyl)-3-ethynyltetrahydrofuran-2,3,4-triyl tribenzoate 
• 1443997-99-6 C₃₇H₃₀O₉ 
• 1443998-09-1 C₃₃H₂₄ClN₅O₇ 
• 1443998-10-4 C₅₃H₄₀ClN₅O₈ 
• 1443997-56-5 C₂₃H₂₈N₃O₉PS 
• 1443997-57-6 C₂₃H₂₈N₃O₉PS 
• 1207542-76-4 (2R,3R,4R,5R)-4-benzoyloxy-5-benzoyloxymethyl-3-ethynyl-tetrahydrofuran-2,3-diol 

Relevant articles and documents

ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E

The present disclosure is directed toward alkynyl nucleoside analogs, compositions comprising these compounds, and their use for treating hepatitis E infections.

4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

Disclosed are halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections. Such viral infections can include tongaviridae, bunyaviridae, arenaviridae, coronaviridae, flaviviridae, picornaviridae, Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infections.

CYCLIC DINUCLEOTIDES AS STING AGONISTS

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1A, R1B, R1C, R1D, B1, R2A, R2B, R2C, R2D, and R2E are defined herein and Formula (II), wherein R1H, R1K, R1J, and R2L are defined herein.